Tower Research Capital LLC (Trc) Soligenix, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.4 - $168.0 $352 - $148,176	882 Added 4.79%	19,289 $9,000
Q3 2022 Nov 10, 2022	BUY	$0.51 - $117.79 $2,561 - $591,541	5,022 Added 37.52%	18,407 $8,000
Q2 2022 Aug 15, 2022	BUY	$0.4 - $0.75 $1,936 - $3,631	4,842 Added 56.68%	13,385 $8,000
Q1 2022 May 12, 2022	BUY	$0.61 - $0.75 $5,211 - $6,407	8,543 New	8,543 $6,000
Q3 2021 Nov 15, 2021	SELL	$0.9 - $1.31 $1,074 - $1,564	-1,194 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$0.87 - $1.58 $53 - $96	61 Added 5.38%	1,194 $1,000
Q1 2021 May 17, 2021	SELL	$1.31 - $2.35 $21,131 - $37,907	-16,131 Reduced 93.44%	1,133 $2,000
Q4 2020 Feb 16, 2021	BUY	$1.26 - $2.75 $5,730 - $12,507	4,548 Added 35.77%	17,264 $22,000
Q3 2020 Nov 16, 2020	BUY	$1.7 - $2.61 $16,542 - $25,397	9,731 Added 326.0%	12,716 $23,000
Q2 2020 Aug 13, 2020	BUY	$1.36 - $2.26 $4,059 - $6,746	2,985 New	2,985 $6,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $152M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.